Thromb Haemost 2007; 97(05): 866-868
DOI: 10.1160/TH06-04-0195
Letters to the Editor
Schattauer GmbH

Any effect of CYP2C9 variants on warfarin clearance in Chinese patients?

Joyce H. S. You
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Zhong Zuo
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Cindy M. Y. Lo
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Limin Zhou
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Hillary H. W. Yiu
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Carrie T. S. Chau
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Kai Chow Choi
2   Centre for Epidemiology and Biostatistics, The Chinese University of Hong Kong
,
David K. M. Choi
1   School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong
,
Raymond S. M. Wong
3   Division of Haematology, Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong; Hong Kong
,
Gregory Cheng
3   Division of Haematology, Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong; Hong Kong
› Institutsangaben
Financial support: The study was supported by a Direct Grant for Research (project code: 2041154) from The Chinese University of Hong Kong.
Weitere Informationen

Publikationsverlauf

Received 09. April 2006

Accepted after resubmission 21. Februar 2007

Publikationsdatum:
24. November 2017 (online)